Recombinant glycoprotein B vaccine formulation with Toll-like receptor 9 agonist and immune-stimulating complex induces specific immunity against multiple strains of cytomegalovirus

Evasion of CD8+ T Cells Is Critical for Superinfection by Cytomegalovirus

(2010) S. G. Hansen et al.   SCIENCE

Birth Prevalence and Natural History of Congenital Cytomegalovirus Infection in a Highly Seroimmune Population

(2009) Marisa M. Mussi‐Pinhata et al.   CLINICAL INFECTIOUS DISEASES

Immunobiology of Human Cytomegalovirus: from Bench to Bedside

(2009) T. Crough et al.   CLINICAL MICROBIOLOGY REVIEWS

Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant

(2009) Robert F. Pass   JOURNAL OF CLINICAL VIROLOGY

Cytomegalovirus Reinfections in Healthy Seroimmune Women

(2009) Shannon A. Ross et al.   JOURNAL OF INFECTIOUS DISEASES

Vaccine Prevention of Maternal Cytomegalovirus Infection

(2009) Robert F. Pass et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical correlations of human cytomegalovirus strains and viral load in kidney transplant recipients

(2008) Eliana Nogueira et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Induction of Pluripotent Protective Immunity Following Immunisation with a Chimeric Vaccine against Human Cytomegalovirus

(2008) Jie Zhong et al.   PLoS One

Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection

(2008) Xiaohong Cui et al.   VACCINE